Project Details
Description
A Single Agent Phase II Study of Depsipeptide (FK228)in the Treatment of Cutaneous T-cell Lymphoma
| Status | Finished |
|---|---|
| Effective start/end date | 2/9/06 → 6/30/08 |
Funding
- CHARLES RIVER LAB, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.